articlesApril 19, 2026·8 min read

Peptide Muscle Timeline: Week-by-Week Results

Weeks 1-2: sleep and recovery. 4-8: body comp shift. 12+: measurable mass. Realistic expectations across 5 stacks.

Peptide Muscle Timeline: Week-by-Week Results

This is the realistic timeline for peptide muscle-building, compiled from the clinical data, vendor protocols, and patterns reported by experienced users. If you're on the fence about starting a peptide stack or you're in week 3 of your first cycle wondering if anything is happening, this article is for you.

Short answer: weeks 1-2 you feel it (sleep, recovery), weeks 4-8 you see early physique changes, weeks 12+ you measure real lean mass gains. Anyone promising faster is either selling something or confusing water weight with muscle.

The Generic Timeline (GH Peptide Stacks)

This applies to the main injectable GHRH+GHRP stacks — CJC-1295 + ipamorelin, tesamorelin + ipamorelin, sermorelin + ipamorelin — which all work through the same GH/IGF-1 mechanism at different strengths.

Week 1: Sleep Changes

The first thing almost everyone notices within 2-3 days of starting: deeper sleep. The pre-bed GHRH+GHRP pulse aligns with the body's natural early slow-wave sleep GH release window, and users consistently report one or more of:

  • Falling asleep faster
  • Waking less during the night
  • Vivid or lucid dreams
  • Feeling more rested on the same hours of sleep

Physical changes at week 1: Minimal. Possibly 1-2 lb of water weight on the scale (not real muscle). Mild hand tingling or joint ache in some users — GH-related fluid shifts.

Week 2-3: Recovery Acceleration

By week 2, training recovery improves noticeably. Specific signs:

  • DOMS (delayed onset muscle soreness) resolves faster
  • Able to train the same muscle group sooner without feeling flat
  • Joint/tendon aches from previous training feel less acute
  • Morning stiffness reduced

Gym performance: starts improving modestly. 2-5 lb added to working sets on compound lifts is typical by the end of week 3.

Week 4-6: Body Composition Shift (First Visible Signs)

Visceral fat starts dropping first. Users report:

  • Waistline measurement down 0.5-1 inch
  • Slightly better muscle definition (especially in the shoulders and arms — areas with less subcutaneous fat)
  • Possibly a slight "fuller" look to muscles (GH-mediated glycogen retention)

This is the first week where a photo comparison to baseline might show a difference. Not dramatic, but measurable.

Expected IGF-1 on week-4 bloodwork: 30-60% above baseline. If baseline was 150 ng/mL, expect 200-240 ng/mL. If IGF-1 hasn't moved, something is wrong — troubleshoot.

Week 6-8: Accumulating Changes

By week 8, the body-composition trajectory is clear. Typical pattern in a trained lifter:

  • 0.5-1.5 lb of visible fat loss
  • 1-2 lb lean mass gain
  • Measurable strength increases (3-8% on major compound lifts)
  • Sleep improvements are stable

Week 8-12: Measurable Lean Mass

This is where the lean mass accrual actually shows up on measurements, photos, and DXA if you're using one. Typical cycle-long numbers:

  • CJC-1295 + ipamorelin: 2-3 lb lean mass gain, 3-5 lb fat loss
  • Tesamorelin + ipamorelin: 3-5 lb lean mass gain, 5-8 lb fat loss, visceral fat reduction of 15% or more

Week 12-16: Consolidation

Some users pull the cycle at week 12; others extend to 16 weeks. The per-week benefit slightly diminishes past week 12 as the body adapts, but the cycle remains productive. By week 16, changes are visible enough to a trained observer to spot.

Week-by-Week Physique Changes

Stack-Specific Timelines

CJC-1295 + Ipamorelin

The canonical starter stack. Timeline:

  • Week 1: Sleep improvements
  • Week 3-4: Recovery and minor performance bumps
  • Week 6-8: Early body-comp changes
  • Week 12: 2-3 lb lean mass, 3-5 lb fat loss
  • Week 16: 3-4 lb lean mass, 4-6 lb fat loss

Budget-conscious, widely stocked, the standard reference point.

Deep dive: Best CJC-1295 + Ipamorelin Vendors | CJC-1295 / Ipamorelin Dosing Guide

Top CJC-1295 + Ipamorelin Vendors

Ranked by price, COA availability, and reputation

Tesamorelin + Ipamorelin

Stronger stack, slightly faster visible changes. Timeline:

  • Week 1: Sleep improvements
  • Week 2-3: Recovery acceleration (faster than CJC+ipa for most users)
  • Week 4-6: First visible body-comp changes (earlier than CJC+ipa)
  • Week 12: 3-4 lb lean mass, 5-7 lb fat loss, significant visceral reduction
  • Week 16: 3-5 lb lean mass, 6-9 lb fat loss

The phase III trial data backs this up: tesamorelin's 26-week RCT showed 15-18% visceral fat reduction — a magnitude you won't see on CJC+ipa.

Deep dive: Best Tesamorelin + Ipamorelin Vendors

Top Tesamorelin + Ipamorelin Vendors

Ranked by price, COA availability, and reputation

Sermorelin + Ipamorelin

Gentler stack, slightly slower visible changes but the same eventual trajectory. Timeline:

  • Week 1-2: Sleep improvements (may feel less dramatic than CJC or tesa)
  • Week 6-8: First body-comp changes (later than CJC+ipa)
  • Week 12: 1.5-2.5 lb lean mass, 2-4 lb fat loss
  • Week 16: 2-3 lb lean mass, 3-5 lb fat loss

Right for over-50 users or anyone new to GH peptides who wants the most conservative entry.

Deep dive: Best Sermorelin Vendors

MK-677 (Oral)

Different pharmacology — sustained GH elevation rather than pulsatile, 24-hour half-life per dose. Timeline:

  • Week 1: Sleep and appetite changes (pronounced)
  • Week 1-4: Water retention phase (2-5 lb fluid gain, not real muscle — many first-timers mistake this for fast results)
  • Week 4-8: Fluid retention stabilizes, real body-comp starts
  • Week 12: Appetite and sleep effects clear; 1-2 lb lean mass
  • Week 52 (in Nass 2008 trial): 1.6 kg fat-free mass vs placebo

MK-677 is a slower muscle-builder than the injectables but works long-term. The Nass 2008 12-month RCT is the best data we have for its timeline.

IGF-1 LR3 (Advanced)

Faster lean mass accrual than GHRH+GHRP alone because it bypasses the GH axis and acts directly on muscle IGF-1 receptors. Timeline:

  • Week 1-2: Noticeable muscle fullness, possibly within days
  • Week 3-4: Strength gains and visible hypertrophy
  • Week 4-6: Target cycle length — pull out at 6 weeks max
  • Post-cycle: Maintain gains with GHRH+GHRP base

IGF-1 LR3 is advanced because hypoglycemia risk is real. Only run after a full GHRH+GHRP cycle has established baseline tolerance.

Deep dive: Best IGF-1 LR3 Vendors

Stack Comparison Timeline

What Could Go Wrong at Each Stage

Week 1, no sleep change: Most likely injection timing (too close to a meal), dose too low, or reconstitution error. Re-verify arithmetic and try injecting 30-60 minutes before actually trying to sleep, on a truly empty stomach.

Week 4, no IGF-1 change: Peptide quality issue (degraded product, counterfeit, underdosed vial), chronic reconstitution error, or injection into muscle instead of fat. Get bloodwork if you haven't.

Week 4, excessive water retention: Possible CJC-1295 DAC contamination (the DAC version causes non-pulsatile GH elevation and more fluid retention). Or you're injecting at too high a dose. Drop to 75 mcg of each peptide for 2 weeks.

Week 6-8, still no visible change but bloodwork confirms IGF-1 elevation: Almost always training or nutrition. Check protein intake, lifting intensity, and sleep.

Week 12, weight up but strength flat: Likely water/fat gain from exceeding calorie intake. The peptide is doing its job; your nutrition isn't.

Tracking What Matters

Weekly:

  • Major compound lifts (squat, deadlift, bench, row): working weight × reps × sets
  • Waist measurement (over the navel, first thing AM, no clothes)
  • Weight (first thing AM)

Biweekly:

  • Body fat estimate (calipers, BIA scale, or tape measurements)
  • Progress photos: front, side, back in the same lighting

At 4 and 12 weeks:

  • IGF-1
  • Fasting glucose, HbA1c
  • Whatever else your baseline included

Frequently Asked Questions

Why do peptides take so long to show visible results?

The GH/IGF-1 axis produces muscle changes through the same pathways your body uses naturally — just amplified. Protein synthesis, collagen turnover, and muscle fiber repair operate on biological timescales that don't shortcut. First 2 weeks: feel it. Weeks 4-8: see it. Week 12+: measure it.

If I don't see anything by week 4, is my peptide bad?

Possibly, but more often it's reconstitution or injection technique. Re-verify arithmetic, confirm pre-bed empty-stomach dosing, rule out underdosing. Bloodwork IGF-1 at week 4 is the objective test.

What should IGF-1 look like on a proper cycle?

At 4 weeks, IGF-1 should be 30-60% above your baseline. If baseline was 150 ng/mL, expect 200-240 ng/mL. If IGF-1 hasn't moved, troubleshoot before continuing.

Does the timeline differ for tesamorelin vs CJC-1295?

Slightly. Tesamorelin produces a larger per-mg GH pulse so visible visceral fat reduction may show up 1-2 weeks earlier. Measurable lean mass still takes 12+ weeks either way.

Does MK-677 work faster than injectables?

No, slower in some ways. MK-677 fluid retention shows up in week 1 and looks like fast results but isn't real muscle. Actual lean mass gain follows the same 8-12 week timeline as injectables, with more water weight early.

How long do the results last after I stop?

Lean mass gained on a cycle partially holds post-cycle if training and protein are maintained. Most users retain 60-80% of lean tissue at 8 weeks post-cycle. GH elevation returns to baseline within 2-4 weeks of stopping.

Can I run two cycles back to back for faster results?

Not recommended. GHRP receptor desensitization is documented with continuous use. Skip the off-cycle and you'll see diminishing returns by cycle 2. Correct approach: 12-16 weeks on, 4-8 off, repeat.

References

# Citation PMID
1 Bowers CY, et al. GH-releasing peptide acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990;70(4):975-982. 2108187
2 Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805. 16352683
3 Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. 9849822
4 Falutz J, et al. Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation. J Clin Endocrinol Metab. 2010;95(9):4291-4304. 20101189
5 Adrian S, et al. Tesamorelin decreases muscle fat and increases muscle area in adults with HIV. J Frailty Aging. 2019;8(3):154-159. 31237318
6 Nass R, et al. Effects of an oral ghrelin mimetic on body composition in healthy older adults. Ann Intern Med. 2008;149(9):601-611. 18981485
7 Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients. JAMA. 2014;312(4):380-389. 25038357